Five-Year Clinical Outcomes of Low-Add-Power Segmented Rotationally Asymmetrical Intraocular Lens

Abstract Introduction This study assessed 5-year results of rotationally asymmetric multifocal intraocular lens (IOL) with +1.5 diopters (D) near addition (Lentis Comfort LS-313 MF15, Teleon Surgical B.V., Spankeren, Netherlands). Methods In 38 eyes of 20 patients (76.8 ± 4.6 years) who were examine...

Full description

Bibliographic Details
Main Authors: Tetsuro Oshika, Hiroyuki Arai, Yasushi Inoue, Yoshifumi Fujita
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-03-01
Series:Ophthalmology and Therapy
Subjects:
Online Access:https://doi.org/10.1007/s40123-023-00703-2
Description
Summary:Abstract Introduction This study assessed 5-year results of rotationally asymmetric multifocal intraocular lens (IOL) with +1.5 diopters (D) near addition (Lentis Comfort LS-313 MF15, Teleon Surgical B.V., Spankeren, Netherlands). Methods In 38 eyes of 20 patients (76.8 ± 4.6 years) who were examined at both 1 and 5 years after surgery, clinical data were retrospectively collected. Results Corrected and uncorrected distance visual acuity (5 m) and uncorrected and distance-corrected intermediate visual acuity (70 cm) were excellent, with no significant differences between 1 and 5 years after surgery. Uncorrected and distance-corrected near visual acuity (30 cm) remained lower. Contrast sensitivity was within the normal range at both 1 and 5 years. The percentage of patients who reported “never or hardly use spectacles” for far, intermediate, and near vision was 95.0%, 85.0%, and 35.0%, respectively. Glare and halo were slightly increased from 1 to 5 years after surgery, but the severity remained none or mild. All patients reported “very high” or “high” level of overall satisfaction. There were no notable postoperative complications. Conclusions During 5 years after surgery, low-add-power segmented multifocal IOL maintained excellent distance and intermediate visual acuity as well as good contrast sensitivity. Glare and halo symptoms were mild, and patients’ satisfaction level was high. Trial Registration University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR) identifier UMIN000048353.
ISSN:2193-8245
2193-6528